监管驱动下的行业重塑：2026 版GCP 修订对临床试验生态的影响与启示
徐岩, 张海洪, 张萍, 张晓方, 李海燕
Reshaping the Clinical Trial Ecosystem Through a Regulatory Lens: The 2026 GCP Revision and Its Impact
XU Yan, ZHANG Hai-hong, ZHANG Ping, ZHANG Xiao-fang, LI Hai-yan
中国食品药品监管
.
2026, (10): 56
-63
.
DOI: 10.3969/j.issn.1673-5390.2026.10.006
京公网安备11010802023381号